Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip A Kalra

Showing results (1-10 of 363) with videos related to

Pageof 37
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 27, 2010
Renal revascularization for heart failure in patients with atherosclerotic renovascular diseasePhilip A Kalra
Clinical Medicine (London, England)|July 29, 2009
Clinical management of atheromatous renovascular diseasePhilip A Kalra
NDT Plus|April 6, 2016
Introducing iron isomaltoside 1000 (Monofer®)-development rationale and clinical experiencePhilip A Kalra
International Journal of Nephrology and Renovascular Disease|March 30, 2016
Efficacy and safety of iron isomaltoside (Monofer(®)) in the management of patients with iron deficiency anemiaPhilip A Kalra, Sunil Bhandari
Postepy W Kardiologii Interwencyjnej = Advances in Interventional Cardiology|October 24, 2017
Atherosclerotic renovascular disease - epidemiology, treatment and current challengesDiana Vassallo, Philip A Kalra
Current Opinion in Nephrology and Hypertension|August 25, 2016
Safety of intravenous iron use in chronic kidney diseasePhilip A Kalra, Sunil Bhandari
British Journal of Hospital Medicine (London, England : 2005)|February 25, 2025
Iron in Chronic Kidney Disease and End-Stage Kidney Disease-Current Trends and Future DirectionThomas McDonnell, Philip A Kalra
Journal of Renal Care|December 19, 2008
Atheromatous renovascular disease: overview and challengesConstantina Chrysochou, Philip A Kalra
Journal of Renal Care|July 1, 2010
Atherosclerotic renovascular disease and the heartConstantina Chrysochou, Philip A Kalra
Nephron. Clinical Practice|February 27, 2010
Current management of atherosclerotic renovascular disease--what have we learned from ASTRAL?Constantina Chrysochou, Philip A Kalra
Pageof 37

Showing results (1-10 of 363) with videos related to

Sort By:
Pageof 37
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 27, 2010
Renal revascularization for heart failure in patients with atherosclerotic renovascular diseasePhilip A Kalra
Clinical Medicine (London, England)|July 29, 2009
Clinical management of atheromatous renovascular diseasePhilip A Kalra
NDT Plus|April 6, 2016
Introducing iron isomaltoside 1000 (Monofer®)-development rationale and clinical experiencePhilip A Kalra
International Journal of Nephrology and Renovascular Disease|March 30, 2016
Efficacy and safety of iron isomaltoside (Monofer(®)) in the management of patients with iron deficiency anemiaPhilip A Kalra, Sunil Bhandari
Postepy W Kardiologii Interwencyjnej = Advances in Interventional Cardiology|October 24, 2017
Atherosclerotic renovascular disease - epidemiology, treatment and current challengesDiana Vassallo, Philip A Kalra
Current Opinion in Nephrology and Hypertension|August 25, 2016
Safety of intravenous iron use in chronic kidney diseasePhilip A Kalra, Sunil Bhandari
British Journal of Hospital Medicine (London, England : 2005)|February 25, 2025
Iron in Chronic Kidney Disease and End-Stage Kidney Disease-Current Trends and Future DirectionThomas McDonnell, Philip A Kalra
Journal of Renal Care|December 19, 2008
Atheromatous renovascular disease: overview and challengesConstantina Chrysochou, Philip A Kalra
Journal of Renal Care|July 1, 2010
Atherosclerotic renovascular disease and the heartConstantina Chrysochou, Philip A Kalra
Nephron. Clinical Practice|February 27, 2010
Current management of atherosclerotic renovascular disease--what have we learned from ASTRAL?Constantina Chrysochou, Philip A Kalra
Pageof 37